MARKET

RVMD

RVMD

Revolution Medicines, Inc.
NASDAQ
190.46
+0.47
+0.25%
Pre Market: 188.42 -2.04 -1.07% 08:07 07/08 EDT
OPEN
189.65
PREV CLOSE
189.99
HIGH
192.92
LOW
186.56
VOLUME
736
TURNOVER
0
52 WEEK HIGH
193.69
52 WEEK LOW
34.00
MARKET CAP
40.49B
P/E (TTM)
-26.8507
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-U.S. STOCKS ON THE MOVE-Vera Therapeutics, Vera Therapeutics, Nvidia
Reuters · 18h ago
BUZZ-U.S. STOCKS ON THE MOVE-Revolution Medicines, Vivani Medical, Nvidia
Reuters · 20h ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 21h ago
EMA accelerates assessment of Revolution Medicines daraxonrasib
TipRanks · 22h ago
EMA starts phased review of Revolution Medicines’ daraxonrasib for pancreatic cancer
PUBT · 23h ago
EUROPEAN MEDICINES AGENCY EXPEDITES ASSESSMENT OF REVOLUTION MEDICINES’ DARAXONRASIB UNDER PHASED REVIEW PROCESS
Reuters · 23h ago
Revolution Medicines wins EU fast track review for cancer drug
Seeking Alpha · 23h ago
BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Crinetics Pharmaceuticals, Rivian Automotive
Reuters · 23h ago
More
About RVMD
Revolution Medicines, Inc. is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Company's research and development pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The Company is advancing a pipeline of RAS(ON) Inhibitors, daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor are in clinical development. The Company's pipeline also focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). The Daraxonrasib, our RAS(ON) multi-selective inhibitor, is designed as an oral, tri-complex inhibitor of multiple RAS(ON) variants containing cancer driver mutations at all three of the major RAS mutation hotspot positions, G12, G13, and Q61.

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMD stock methods without spending real money on the virtual paper trading platform.